PostEra
PrivateLast Round
Grant
May 18, 2022
Total Funding Raised
$94.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
PostEra operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Grant round in May 2022.
PostEra is a biotechnology company that offers an AI-driven drug discovery platform that uses machine learning to accelerate medicinal chemistry and optimize small molecule development.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PostEra Comparables
Compare PostEra with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genesis Molecular AI | 90% | |
| Iktos | 86% | |
| Terray Therapeutics | 85% |
For institutional investors. Book with your work email.
PostEra Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 18, 2022 | ||||
| Series A | Jan 11, 2022 | ||||
| Seed | Mar 30, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
PostEra Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Breyer Capital | Series A |
| I2BF Global Ventures | Series A |
| Pioneer Fund | Series A, Seed |
| Metaplanet Holdings | Series A, Seed |
| NIH RADx | Grant |
| Lifeforce Capital | Series A |
| Pioneer Fund | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 66% MoM.
- Jul 24, 2026
Monthly visitors grew 44% MoM, from 1.4K to 2K.
For institutional investors. Book with your work email.
PostEra Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PostEra's valuation, stock price, and market status.
Is PostEra a public or private company?
PostEra is a private company.
What is the current stock price of PostEra?
PostEra is a private company, so its shares have no public market price. Caplight tracks PostEra's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PostEra worth (valuation)?
Valuation information for PostEra is not publicly available.
Can I buy PostEra stock?
PostEra shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PostEra's last funding round?
PostEra's most recent funding round was Grant on May 18, 2022.
Who are the main investors in PostEra?
Key investors in PostEra include NIH RADx, Y Combinator, The Clermont Group.
Will PostEra IPO soon?
No public IPO plans have been announced for PostEra.
How can I track PostEra secondary market activity?
Caplight tracks bids, offers, and trades in PostEra's shares on secondary markets.